Search Results - "Aliper, Alex"

Refine Results
  1. 1

    Artificial intelligence for aging and longevity research: Recent advances and perspectives by Zhavoronkov, Alex, Mamoshina, Polina, Vanhaelen, Quentin, Scheibye-Knudsen, Morten, Moskalev, Alexey, Aliper, Alex

    Published in Ageing research reviews (01-01-2019)
    “…The applications of modern artificial intelligence (AI) algorithms within the field of aging research offer tremendous opportunities. Aging is an almost…”
    Get full text
    Journal Article
  2. 2

    Biohorology and biomarkers of aging: Current state-of-the-art, challenges and opportunities by Galkin, Fedor, Mamoshina, Polina, Aliper, Alex, de Magalhães, João Pedro, Gladyshev, Vadim N., Zhavoronkov, Alex

    Published in Ageing research reviews (01-07-2020)
    “…[Display omitted] Telomere length, gene expression, blood chemical parameters and DNA-methylation status all undergo age-associated changes, which can be…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Human Gut Microbiome Aging Clock Based on Taxonomic Profiling and Deep Learning by Galkin, Fedor, Mamoshina, Polina, Aliper, Alex, Putin, Evgeny, Moskalev, Vladimir, Gladyshev, Vadim N., Zhavoronkov, Alex

    Published in iScience (26-06-2020)
    “…The human gut microbiome is a complex ecosystem that both affects and is affected by its host status. Previous metagenomic analyses of gut microflora revealed…”
    Get full text
    Journal Article
  5. 5

    High-confidence cancer patient stratification through multiomics investigation of DNA repair disorders by Mkrtchyan, Garik V., Veviorskiy, Alexander, Izumchenko, Evgeny, Shneyderman, Anastasia, Pun, Frank W., Ozerov, Ivan V., Aliper, Alex, Zhavoronkov, Alex, Scheibye-Knudsen, Morten

    Published in Cell death & disease (26-11-2022)
    “…Multiple cancer types have limited targeted therapeutic options, in part due to incomplete understanding of the molecular processes underlying tumorigenesis…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    druGAN: An Advanced Generative Adversarial Autoencoder Model for de Novo Generation of New Molecules with Desired Molecular Properties in Silico by Kadurin, Artur, Nikolenko, Sergey, Khrabrov, Kuzma, Aliper, Alex, Zhavoronkov, Alex

    Published in Molecular pharmaceutics (05-09-2017)
    “…Deep generative adversarial networks (GANs) are the emerging technology in drug discovery and biomarker development. In our recent work, we demonstrated a…”
    Get full text
    Journal Article
  9. 9

    Adversarial Threshold Neural Computer for Molecular de Novo Design by Putin, Evgeny, Asadulaev, Arip, Vanhaelen, Quentin, Ivanenkov, Yan, Aladinskaya, Anastasia V, Aliper, Alex, Zhavoronkov, Alex

    Published in Molecular pharmaceutics (01-10-2018)
    “…In this article, we propose the deep neural network Adversarial Threshold Neural Computer (ATNC). The ATNC model is intended for the de novo design of novel…”
    Get full text
    Journal Article
  10. 10

    Quantum computing for near-term applications in generative chemistry and drug discovery by Pyrkov, Alexey, Aliper, Alex, Bezrukov, Dmitry, Lin, Yen-Chu, Polykovskiy, Daniil, Kamya, Petrina, Ren, Feng, Zhavoronkov, Alex

    Published in Drug discovery today (01-08-2023)
    “…•Drug discovery is time consuming, expensive and experiences increasing challenges.•Generation of new drug candidates is one of the major challenges.•Quantum…”
    Get full text
    Journal Article
  11. 11

    Prediction of Clinical Trials Outcomes Based on Target Choice and Clinical Trial Design with Multi‐Modal Artificial Intelligence by Aliper, Alex, Kudrin, Roman, Polykovskiy, Daniil, Kamya, Petrina, Tutubalina, Elena, Chen, Shan, Ren, Feng, Zhavoronkov, Alex

    Published in Clinical pharmacology and therapeutics (01-11-2023)
    “…Drug discovery and development is a notoriously risky process with high failure rates at every stage, including disease modeling, target discovery, hit…”
    Get full text
    Journal Article
  12. 12

    Chemistry42: An AI-Driven Platform for Molecular Design and Optimization by Ivanenkov, Yan A., Polykovskiy, Daniil, Bezrukov, Dmitry, Zagribelnyy, Bogdan, Aladinskiy, Vladimir, Kamya, Petrina, Aliper, Alex, Ren, Feng, Zhavoronkov, Alex

    “…Chemistry42 is a software platform for de novo small molecule design and optimization that integrates Artificial Intelligence (AI) techniques with…”
    Get full text
    Journal Article
  13. 13

    Discovery of 3-hydroxymethyl-azetidine derivatives as potent polymerase theta inhibitors by Wang, Yazhou, Wang, Chao, Liu, Jinxin, Sun, Deheng, Meng, Fanye, Zhang, Man, Aliper, Alex, Ren, Feng, Zhavoronkov, Alex, Ding, Xiao

    Published in Bioorganic & medicinal chemistry (01-04-2024)
    “…[Display omitted] Inhibition of the low fidelity DNA polymerase Theta (Polθ) is emerging as an attractive, synthetic-lethal antitumor strategy in…”
    Get full text
    Journal Article
  14. 14

    COSMIC: Molecular Conformation Space Modeling in Internal Coordinates with an Adversarial Framework by Kuznetsov, Maksim, Ryabov, Fedor, Schutski, Roman, Shayakhmetov, Rim, Lin, Yen-Chu, Aliper, Alex, Polykovskiy, Daniil

    “…The fast and accurate conformation space modeling is an essential part of computational approaches for solving ligand and structure-based drug discovery…”
    Get full text
    Journal Article
  15. 15

    Discovery of Tetrahydropyrazolopyrazine Derivatives as Potent and Selective MYT1 Inhibitors for the Treatment of Cancer by Wang, Yazhou, Wang, Chao, Liu, Tingting, Qi, Hongyun, Chen, Shan, Cai, Xin, Zhang, Man, Aliper, Alex, Ren, Feng, Ding, Xiao, Zhavoronkov, Alex

    Published in Journal of medicinal chemistry (11-01-2024)
    “…Breast and gynecological cancers are among the leading causes of death in women worldwide, illustrating the urgent need for innovative treatment options. We…”
    Get full text
    Journal Article
  16. 16

    Discovery of a Novel and Potent Cyclin-Dependent Kinase 8/19 (CDK8/19) Inhibitor for the Treatment of Cancer by Xu, Jianyu, Qi, Hongyun, Wang, Zhen, Wang, Ling, Steurer, Barbara, Cai, Xin, Liu, Jinxin, Aliper, Alex, Zhang, Man, Ren, Feng, Zhavoronkov, Alex, Ding, Xiao

    Published in Journal of medicinal chemistry (23-05-2024)
    “…The mediator kinases CDK8 and CDK19 control the dynamic transcription of selected genes in response to various signals and have been shown to be hijacked to…”
    Get full text
    Journal Article
  17. 17
  18. 18

    TNIK’s emerging role in cancer, metabolism, and age-related diseases by Ewald, Collin Y., Pulous, Fadi E., Lok, Sarah Wing Yan, Pun, Frank W., Aliper, Alex, Ren, Feng, Zhavoronkov, Alex

    “…Recent advances have demonstrated that Traf2- and Nck-interacting kinase (TNIK) is a key regulator of physiological and pathological metabolic signaling during…”
    Get full text
    Journal Article
  19. 19

    Discovery of novel and selective SIK2 inhibitors by the application of AlphaFold structures and generative models by Zhu, Wei, Liu, Xiaosong, Li, Qi, Gao, Feng, Liu, Tingting, Chen, Xiaojing, Zhang, Man, Aliper, Alex, Ren, Feng, Ding, Xiao, Zhavoronkov, Alex

    Published in Bioorganic & medicinal chemistry (15-08-2023)
    “…[Display omitted] Salt-inducible kinase 2 (SIK2) has been recognized as a potential target for anti-inflammation and anti-cancer therapy. In this paper, based…”
    Get full text
    Journal Article
  20. 20

    Discovery of Novel and Potent Prolyl Hydroxylase Domain-Containing Protein (PHD) Inhibitors for The Treatment of Anemia by Xu, Jianyu, Ding, Xiaoyu, Fu, Yanyun, Meng, Qingyuan, Wang, Ling, Zhang, Man, Xu, Chenxi, Chen, Shan, Aliper, Alex, Ren, Feng, Zhavoronkov, Alex, Ding, Xiao

    Published in Journal of medicinal chemistry (25-01-2024)
    “…Stabilization of hypoxia-inducible factor (HIF) by inhibiting prolyl hydroxylase domain enzymes (PHDs) represents a breakthrough in treating anemia associated…”
    Get full text
    Journal Article